Other headlinesZiehm, BrainLAB strengthen alliance
New moniker better fits telerad firm
Teleradiology firm Optimal Reading Services Group is rebranding itself as Optimal IMX, a change that reflects the broad mission and offerings of the company. Rather than just providing interpretations, the three-year-old Birmingham, AL, company is framing itself as the means to increase the capacity, productivity, and quality of hospitals and radiology groups. Optimal IMX claims customers in more than 30 states, making it one of the largest U.S. radiology practices. Staff specializing in teleradiology and practice management provide interpretations and advice designed to increase radiology coverage, improve workflow and financial management, and market services. Services are designed to address slow turnaround of radiology reports, low morale, and reduced effectiveness, a shortage of on-site subspecialty skills, and unequal distribution of radiology expertise across a healthcare system.
Ziehm, BrainLAB strengthen alliance
Ziehm Imaging has put in place an interface that allows high-resolution 3D images from its mobile C-arm to be used for surgical navigation during interventions performed using navigational software from BrainLAB. The new Ziehm NaviPort interface works in combination with its flat-detector Vision FD Vario 3D C-arm and BrainLAB’s fluoro 3D software. The software automatically matches the C-arm dataset taken during the surgery with the anatomy of the patient, showing the movement of surgical instrument on the monitor in real time. The interface is currently in use at Department for Trauma, Reconstructive and Plastic Surgery at Leipzig University Clinic.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.